Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy

BACKGROUND: Previous pharmacokinetic studies with docetaxel have mostly used 3-weekly (75 mg/m(2 )and 100 mg/m(2)) or weekly regimens (35–40 mg/m(2)). The pharmacokinetics and radiosensitizing efficacy of weekly 20 mg/m(2 )docetaxel, has however not been well characterized. We examined the pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Fr Brunsvig, Paal, Andersen, Anders, Aamdal, Steinar, Kristensen, Vessela, Olsen, Harald
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175508/
https://www.ncbi.nlm.nih.gov/pubmed/17956601
http://dx.doi.org/10.1186/1471-2407-7-197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175508/
https://www.ncbi.nlm.nih.gov/pubmed/17956601
http://dx.doi.org/10.1186/1471-2407-7-197

Ejemplares similares